| Literature DB >> 25103781 |
Ariana L C de Paiva1, Talyta L Nunes, Maria G C de Oliveira, Alessandro M L de Morais, Erika A A Dos Santos, Alexandre R Silva, Moacir F de Oliveira, Valéria V de Paula.
Abstract
BACKGROUND: Alpha adrenergic drugs are usually used in the treatment of erectile and ejaculatory dysfunction in humans. The influence of such drugs on the seminal characteristics of wild animals has not been verified; whereas their impact on the seminal characteristics and erectile and ejaculatory functions of collared peccaries (Tayassu tajacu) has already been determined. This study aimed at investigating and comparing the effects of medetomidine and atipamezole on the seminal variables of collared peccaries undergoing electroejaculation as well as at determining whether these drugs affected the erectile and ejaculatory functions of this species.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25103781 PMCID: PMC4236823 DOI: 10.1186/s12917-014-0170-2
Source DB: PubMed Journal: BMC Vet Res ISSN: 1746-6148 Impact factor: 2.741
Mean values ± SE for the percentage of collared peccaries ( ) that had an erection according to different anesthesia protocols
| | ||||||
|---|---|---|---|---|---|---|
| Erection | ||||||
| Yes | 9 | 75 | 8 | 66.7 | 7 | 58.3 |
| No | 3 | 25 | 4 | 33.3 | 5 | 41.7 |
There was no significant difference in the results between treatments.
P-propofol alone; MP-medetomidine/propofol; AP-atipamezole/propofol treatments.
Mean values ± SE for the ejaculation latency time (minutes) of the collared peccaries ( ) that underwent electroejaculation according to different anesthesia protocols
| P | 2.66 ± 1.41BC | 1.0 | 5.0 |
| AP | 4.27 ± 2.45A | 1.0 | 9.0 |
| MP | 3.9 ± 2.42AB | 1.0 | 8.0 |
A-CValues with different superscripts differ significantly in column (P < 0.05).
P-propofol alone; MP-medetomidine/propofol; AP-atipamezole/propofol treatments.
Mean values ± SE of semen parameters of collared peccaries ( ) according to different anesthesia protocols
| Volume (μL) | 2520.0 ± 603.1a | 0-7000.0 | 1640 ± 329.3a | 0-3500.0 | 1454.9 ± 784.3a | 50-9000.0 |
| Motility (%) | 90.5 ± 3.1a | 70-100 | 84.5 ± 6.3a | 30-95 | 84.6 ± 4.2a | 60-100 |
| Vigor | 3.7 ± 0.5a | 3-5 | 3.5 ± 0.5a | 2-5 | 4.0 ± 0.3a | 2-5 |
| Alive (%) | 65.10 ± 7.0a | 29-98 | 72.8 ± 3.1a | 58-88 | 71.27 ± 4.4a | 0-95 |
| Concentration( x 106 sperm/mL) | 180.0 ± 0.7ab | 10-510 | 220.2 ± 49.7a | 30-550 | 100.0 ± 25.86b | 20-280 |
| Functional integrity of the membrane (%) | 82.3 ± 7.9a | 20-95 | 80.50 ± 4.2a | 57-98 | 88.5 ± 2.7a | 69-95 |
a-bValues with different superscripts differ significantly in line (P < 0.05).
P-propofol alone; MP-medetomidine/propofol; AP-atipamezole/propofol treatments.